Novo Nordisk A/S ADR buy The Goldman Sachs Group, Inc.
Start price
30.05.24
/
50%
€123.00
Target price
30.05.25
€144.02
Performance (%)
-0.44%
Price
19.08.24
€122.00
Summary
This prediction is currently active. Since the start of the prediction for Novo Nordisk A/S ADR the price has only changed by -0.44%. Dividends of €0.46 are taken into consideration when calculating the performance. This prediction currently runs until 30.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | 2.521% | 2.521% |
iShares Core DAX® | 4.097% | 1.280% |
iShares Nasdaq 100 | 5.110% | -0.741% |
iShares Nikkei 225® | 5.333% | -0.280% |
iShares S&P 500 | 3.487% | -0.006% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $156.00 price target on the stock.
Ratings data for NVO provided by MarketBeat